Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets EXMKT - Delayed Quote USD

Cann American Corp. (CNNA)

Compare
0.0042
+0.0004
+(10.53%)
At close: 1:32:13 PM EDT
Loading Chart for CNNA
  • Previous Close 0.0038
  • Open 0.0040
  • Bid --
  • Ask --
  • Day's Range 0.0038 - 0.0042
  • 52 Week Range 0.0003 - 0.0077
  • Volume 1,180,000
  • Avg. Volume 246,520
  • Market Cap (intraday) 1.228M
  • Beta (5Y Monthly) -0.09
  • PE Ratio (TTM) --
  • EPS (TTM) -10.5600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cann American Corp. is a development stage company dedicated to advancing healthcare solutions through innovative therapies. The company focuses on making healthcare affordable and accessible. By leveraging cutting-edge technology, Cann American Corp. aims to reduce costs and improve the availability of high-quality healthcare services for all patients. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was established in 2004 and headquartered in Orlando, Florida.

www.cnnacorp.com

1

Full Time Employees

February 28

Fiscal Year Ends

Recent News: CNNA

View More

Performance Overview: CNNA

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CNNA
31.25%
S&P 500 (^GSPC)
3.58%

1-Year Return

CNNA
7.69%
S&P 500 (^GSPC)
8.94%

3-Year Return

CNNA
30.00%
S&P 500 (^GSPC)
24.75%

5-Year Return

CNNA
76.67%
S&P 500 (^GSPC)
124.42%

Compare To: CNNA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CNNA

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -67.38%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    3.82M

  • Diluted EPS (ttm)

    -10.5600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    59.87k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -4.17M

Research Analysis: CNNA

View More

Company Insights: CNNA

Research Reports: CNNA

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.